Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
March 22, 2025
Exploring currently available fibroblast activation protein targeting molecules in adrenocortical carcinoma: Navigating theranostic pathways
Sejal Chopra, Jaya Shukla, Priyavrat Purohit, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 8, 2024
Targeting CXCR4/CXCL12 axis via [<sup>177</sup>Lu]Lu-DOTAGA.(SA.FAPi)<sub>2</sub> with CXCR4 antagonist in triple-negative breast cancer
Guangfa Bao, Ziqiang Wang, Luoxia Liu, et al.
Clinical Nuclear Medicine
|
January 6, 2025
Biodistribution and Dosimetry Evaluation of the Radiolabeled Somatostatin Receptor Antagonist 68 Ga-DATA 5m LM4 in Molecular Imaging of Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors Patients
Sanjana Ballal, Parvind Sheokand, Madhav P Yadav, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
January 10, 2022
Fibroblast Activation Protein (FAP) targeting homodimeric FAP inhibitor radiotheranostics: a step to improve tumor uptake and retention time
Euy Sung Moon, Sanjana Ballal, Madhav Prasad Yadav, et al.
Cancers
|
March 29, 2023
Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics
Marcel Martin, Sanjana Ballal, Madhav Prasad Yadav, et al.
Clinical Nuclear Medicine
|
February 2, 2023
68 Ga-DOTA.SA.FAPI as a Potential, Noninvasive Diagnostic Probe for Recurrent and Metastatic Adrenocortical Carcinoma : A Head-to-Head Comparison With 18F-FDG
Sejal Chopra, Rama Walia, Yamini Mathur, et al.
Academic Radiology
|
January 17, 2024
<sup>68</sup>Ga-DOTA.SA.FAPi as a Versatile Diagnostic Probe for Various Epithelial Malignancies: A Head-to-Head Comparison with <sup>18</sup>F-FDG
Sejal Chopra, Yamini Mathur, Frank Roesch, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 13, 2021
Novel Fibroblast Activation Protein Inhibitor-Based Targeted Theranostics for Radioiodine-Refractory Differentiated Thyroid Cancer Patients: A Pilot Study
Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 16, 2011
Characterisation of [¹¹C]PR04.MZ in Papio anubis baboon: a selective high-affinity radioligand for quantitative imaging of the dopamine transporter
Patrick J Riss, Jacob M Hooker, Colleen Shea, et al.
Nuklearmedizin. Nuclear Medicine
|
July 13, 2021
Fibroblast activation protein inhibitor (FAPi) positive tumour fraction on PET/CT correlates with Ki-67 in liver metastases of neuroendocrine tumours
Barbara Kreppel, Maria Angeles Gonzalez-Carmona, Georg Feldmann, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
European Journal of Nuclear Medicine and Molecular Imaging
|
March 22, 2025
Exploring currently available fibroblast activation protein targeting molecules in adrenocortical carcinoma: Navigating theranostic pathways
Sejal Chopra, Jaya Shukla, Priyavrat Purohit, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 8, 2024
Targeting CXCR4/CXCL12 axis via [<sup>177</sup>Lu]Lu-DOTAGA.(SA.FAPi)<sub>2</sub> with CXCR4 antagonist in triple-negative breast cancer
Guangfa Bao, Ziqiang Wang, Luoxia Liu, et al.
Clinical Nuclear Medicine
|
January 6, 2025
Biodistribution and Dosimetry Evaluation of the Radiolabeled Somatostatin Receptor Antagonist 68 Ga-DATA 5m LM4 in Molecular Imaging of Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors Patients
Sanjana Ballal, Parvind Sheokand, Madhav P Yadav, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
January 10, 2022
Fibroblast Activation Protein (FAP) targeting homodimeric FAP inhibitor radiotheranostics: a step to improve tumor uptake and retention time
Euy Sung Moon, Sanjana Ballal, Madhav Prasad Yadav, et al.
Cancers
|
March 29, 2023
Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics
Marcel Martin, Sanjana Ballal, Madhav Prasad Yadav, et al.
Clinical Nuclear Medicine
|
February 2, 2023
68 Ga-DOTA.SA.FAPI as a Potential, Noninvasive Diagnostic Probe for Recurrent and Metastatic Adrenocortical Carcinoma : A Head-to-Head Comparison With 18F-FDG
Sejal Chopra, Rama Walia, Yamini Mathur, et al.
Academic Radiology
|
January 17, 2024
<sup>68</sup>Ga-DOTA.SA.FAPi as a Versatile Diagnostic Probe for Various Epithelial Malignancies: A Head-to-Head Comparison with <sup>18</sup>F-FDG
Sejal Chopra, Yamini Mathur, Frank Roesch, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 13, 2021
Novel Fibroblast Activation Protein Inhibitor-Based Targeted Theranostics for Radioiodine-Refractory Differentiated Thyroid Cancer Patients: A Pilot Study
Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 16, 2011
Characterisation of [¹¹C]PR04.MZ in Papio anubis baboon: a selective high-affinity radioligand for quantitative imaging of the dopamine transporter
Patrick J Riss, Jacob M Hooker, Colleen Shea, et al.
Nuklearmedizin. Nuclear Medicine
|
July 13, 2021
Fibroblast activation protein inhibitor (FAPi) positive tumour fraction on PET/CT correlates with Ki-67 in liver metastases of neuroendocrine tumours
Barbara Kreppel, Maria Angeles Gonzalez-Carmona, Georg Feldmann, et al.
Page
of 7